The latest findings in an animal model show that CD8+ T cells play an essential role in anti-CD20-mediated tumor regression but the blockade of regulatory T cells by CTLA-4 can synergize with anti-CD20 (Ren et al., 2017). The gene discussed is CTLA4; the disease is neoplasm.